Hims & Hers Stock Drops More Than 30% After Novo Nordisk Breakup – WSJ
Business News
- Hims & Hers Stock Drops More Than 30% After Novo Nordisk Breakup WSJ
- Hims & Hers stock plunges after Novo Nordisk ends Wegovy direct sales deal Yahoo Finance
- Novo Exits Hims Partnership, Citing Concerns Over Compounded Drugs Bloomberg.com
- Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 28% CNBC
- Novo Nordisk ends deal with Hims due to compounding concerns with obesity drugs STAT
Source: Business News
